Market revenue in 2023 | USD 168.6 million |
Market revenue in 2030 | USD 218.9 million |
Growth rate | 3.8% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 76.93% in 2023. Horizon Databook has segmented the Norway healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
There are various medical device CROs in the country. The growing consolidation in the outsourcing market can be attributed to the CROs expanding their geographical footprints across the globe. For instance, Factory CRO acquired Milestone Research Organization, a U.S.-based CRO, to expand its footprint in North America.
Furthermore, the consolidation trend in this space is expected to continue in the country, thereby driving market growth over the forecast period. The Norwegian government is providing continuous support in promoting clinical trials.
According to February 2024 reports, the Norwegian government plans to fully integrate clinical research into patient treatment and clinical practice. The government has established NorTrials, to promote Norway as a preferred country for clinical trials.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Norway healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account